• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物治疗剂在治疗下尿路症状中的应用:芝加哥大学的认知与使用情况的人口统计学分析

Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago.

作者信息

Bales G T, Christiano A P, Kirsh E J, Gerber G S

机构信息

Department of Surgery, University of Chicago Pritzker School of Medicine, Illinois, USA.

出版信息

Urology. 1999 Jul;54(1):86-9. doi: 10.1016/s0090-4295(99)00028-x.

DOI:10.1016/s0090-4295(99)00028-x
PMID:10414732
Abstract

OBJECTIVES

To assess awareness and use of phytotherapeutic agents in treating lower urinary tract symptoms (LUTS).

METHODS

A survey was conducted of 1280 patients presenting to the University of Chicago Hospitals urology clinic. The questions pertained to age, race, educational level, and use of prescription and nonprescription medications for urinary symptoms.

RESULTS

Of 1264 patients filling out the surveys correctly, the 51 to 60-year-old age range demonstrated the greatest percentage of use of these agents. Whites were nearly twice as likely as their African American counterparts to use medicinal botanicals. Men with college or graduate school degrees were 1.5 times as likely to use medicinal botanicals in treating LUTS. More than 50% of men using phytotherapeutic drugs were also taking prescription medications for the urinary symptoms.

CONCLUSIONS

There is significant use of phytotherapeutic agents in men with LUTS, although there is variability in their use between patient groups. American physicians need some understanding of these agents to best advise and treat their patients.

摘要

目的

评估植物治疗药物在治疗下尿路症状(LUTS)中的知晓率和使用情况。

方法

对前往芝加哥大学医院泌尿外科诊所就诊的1280名患者进行了一项调查。问题涉及年龄、种族、教育程度以及用于治疗泌尿症状的处方药和非处方药的使用情况。

结果

在1264名正确填写调查问卷的患者中,51至60岁年龄段使用这些药物的比例最高。白人使用药用植物的可能性几乎是非洲裔美国人的两倍。拥有大学或研究生学历的男性使用药用植物治疗LUTS的可能性是其他人 的1.5倍。使用植物治疗药物的男性中,超过50%的人也在服用治疗泌尿症状的处方药。

结论

LUTS男性患者中植物治疗药物的使用较为普遍,尽管不同患者群体之间的使用情况存在差异。美国医生需要对这些药物有所了解,以便为患者提供最佳建议和治疗。

相似文献

1
Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago.植物治疗剂在治疗下尿路症状中的应用:芝加哥大学的认知与使用情况的人口统计学分析
Urology. 1999 Jul;54(1):86-9. doi: 10.1016/s0090-4295(99)00028-x.
2
Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.医生对与良性前列腺增生(BPH)症状相关的性功能障碍以及与BPH药物相关的性副作用的看法。
Int J Impot Res. 2007 Jul-Aug;19(4):386-92. doi: 10.1038/sj.ijir.3901540. Epub 2007 Mar 22.
3
Benign prostatic hyperplasia and male lower urinary tract symptoms.良性前列腺增生与男性下尿路症状
Am Fam Physician. 2012 Aug 15;86(4):359-60.
4
Herbal and vitamin supplement use in a prostate cancer screening population.前列腺癌筛查人群中草药和维生素补充剂的使用情况。
Urology. 2004 Feb;63(2):288-92. doi: 10.1016/j.urology.2003.09.019.
5
[Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].[下尿路症状与男性性功能障碍:衰老男性的多国调查(MSAM-7)]
Prog Urol. 2004 Jun;14(3):332-44.
6
The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia.α1肾上腺素能受体拮抗剂在下尿路症状中的应用:超越良性前列腺增生
Urology. 2003 Sep;62(3 Suppl 1):34-41. doi: 10.1016/s0090-4295(03)00472-2.
7
Serenoa repens for benign prostatic hyperplasia.用于良性前列腺增生的锯叶棕。
Cochrane Database Syst Rev. 2002(3):CD001423. doi: 10.1002/14651858.CD001423.
8
Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a multidisciplinary research consensus panel.前列腺动脉栓塞术治疗良性前列腺增生相关下尿路症状及前列腺癌患者出血:多学科研究共识小组会议纪要
J Vasc Interv Radiol. 2014 May;25(5):665-74. doi: 10.1016/j.jvir.2013.11.003. Epub 2014 Feb 21.
9
Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.了解亚太地区、拉丁美洲和独立国家联合体患者及医生对良性前列腺增生的认知:行为与教育前列腺研究(PROBE)II调查
Int J Clin Pract. 2016 Oct;70(10):870-880. doi: 10.1111/ijcp.12879.
10
The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.α受体阻滞剂和5α还原酶抑制剂的摄入对下尿路症状男性性功能健康的影响。
BJU Int. 2007 Oct;100(4):853-7. doi: 10.1111/j.1464-410X.2007.07092.x. Epub 2007 Jul 23.

引用本文的文献

1
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review.当前对前列腺炎中雄激素信号及其治疗的理解:综述。
Curr Med Chem. 2024;31(27):4249-4266. doi: 10.2174/0109298673279207231228070533.
2
Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin.在模拟的非处方环境中对男性下尿路症状的管理:坦索罗辛的探索性研究
Drugs Aging. 2019 Feb;36(2):179-188. doi: 10.1007/s40266-018-0621-8.
3
Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.
雄激素依赖性疾病药物设计与药物发现的最新进展
Curr Med Chem. 2016;23(8):792-815. doi: 10.2174/0929867323666160210125642.
4
Acupuncture for benign prostatic hyperplasia: a systematic review protocol.针灸治疗良性前列腺增生:一项系统评价方案
BMJ Open. 2015 Apr 2;5(4):e007009. doi: 10.1136/bmjopen-2014-007009.
5
Lower urinary tract symptoms in men.男性下尿路症状
BMJ. 2014 Aug 14;349:g4474. doi: 10.1136/bmj.g4474.
6
Promising molecular targets and biomarkers for male BPH and LUTS.有前途的男性 BPH 和 LUTS 的分子靶点和生物标志物。
Curr Urol Rep. 2013 Dec;14(6):628-37. doi: 10.1007/s11934-013-0368-z.
7
Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials.中药治疗良性前列腺增生症的疗效和安全性:随机对照试验的系统评价。
Asian J Androl. 2013 Jul;15(4):471-82. doi: 10.1038/aja.2012.173. Epub 2013 Jun 3.
8
Serenoa repens for benign prostatic hyperplasia.用于良性前列腺增生的锯叶棕。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3.
9
Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.锯叶棕单药治疗良性前列腺增生症(BPH):一项更新的 Cochrane 系统评价。
BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2.
10
Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.招募参与者参加植物疗法治疗良性前列腺增生的临床试验。
J Altern Complement Med. 2011 May;17(5):469-72. doi: 10.1089/acm.2010.0300. Epub 2011 May 9.